$ISIS Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in IONIS PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in IONIS PHARMACEUTICALS INC. Get notifications about new insider transactions in IONIS PHARMACEUTICALS INC for free.
Page: < prev 1 ... 2 3 4 5 6 7 8 9 ... 28 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 29 2018 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | Chief Operating Off ... | Sell | S | 54.00 | 7,500 | 405,000 | 15,841 | 23.3 K to 15.8 K (-32.13 %) |
| Aug 29 2018 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | Chief Operating Off ... | Buy | M | 7.21 | 7,500 | 54,075 | 23,341 | 15.8 K to 23.3 K (+47.35 %) |
| Aug 29 2018 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | Chief Operating Off ... | Sell | S | 54.00 | 8,993 | 485,622 | 15,841 | 24.8 K to 15.8 K (-36.21 %) |
| Aug 29 2018 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | Chief Operating Off ... | Buy | M | 7.25 | 8,993 | 65,199 | 24,834 | 15.8 K to 24.8 K (+56.77 %) |
| Aug 09 2018 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | SVP, Antisense Rese ... | Option Exercise | M | 14.69 | 12,487 | 183,434 | 21,513 | |
| Aug 09 2018 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | SVP, Antisense Rese ... | Option Exercise | M | 7.25 | 13 | 94 | 0 | |
| Aug 09 2018 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | SVP, Antisense Rese ... | Sell | S | 45.00 | 12,487 | 561,915 | 19,396 | 31.9 K to 19.4 K (-39.17 %) |
| Aug 09 2018 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | SVP, Antisense Rese ... | Buy | M | 14.69 | 12,487 | 183,434 | 31,883 | 19.4 K to 31.9 K (+64.38 %) |
| Aug 09 2018 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | SVP, Antisense Rese ... | Sell | S | 45.00 | 13 | 585 | 19,396 | 19.4 K to 19.4 K (-0.07 %) |
| Aug 09 2018 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | SVP, Antisense Rese ... | Buy | M | 7.25 | 13 | 94 | 19,409 | 19.4 K to 19.4 K (+0.07 %) |
| Aug 06 2018 | ISIS | IONIS PHARMACEUTIC ... | IONIS PHARMACEUTICALS INC | 10% Owner | Buy | J | 0.00 | 1,597,571 | 0 | 65,712,116 | 64.1 M to 65.7 M (+2.49 %) |
| Jul 25 2018 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | Chief Operating Off ... | Sell | S | 47.03 | 156 | 7,337 | 15,841 | 16 K to 15.8 K (-0.98 %) |
| Jul 19 2018 | ISIS | IONIS PHARMACEUTIC ... | WENDER JOSEPH H | Director | Option Exercise | M | 9.30 | 15,000 | 139,500 | 0 | |
| Jul 19 2018 | ISIS | IONIS PHARMACEUTIC ... | WENDER JOSEPH H | Director | Option Exercise | M | 9.22 | 15,000 | 138,300 | 0 | |
| Jul 19 2018 | ISIS | IONIS PHARMACEUTIC ... | WENDER JOSEPH H | Director | Buy | M | 9.30 | 15,000 | 139,500 | 68,916 | 53.9 K to 68.9 K (+27.82 %) |
| Jul 19 2018 | ISIS | IONIS PHARMACEUTIC ... | WENDER JOSEPH H | Director | Buy | M | 9.22 | 15,000 | 138,300 | 53,916 | 38.9 K to 53.9 K (+38.54 %) |
| Jul 16 2018 | ISIS | IONIS PHARMACEUTIC ... | McDevitt Damien | Chief Business Offi ... | Option Exercise | A | 0.00 | 14,167 | 0 | 14,167 | |
| Jul 03 2018 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | SVP, Antisense Rese ... | Buy | J | 35.42 | 282 | 9,988 | 19,396 | 19.1 K to 19.4 K (+1.48 %) |
| Jul 03 2018 | ISIS | IONIS PHARMACEUTIC ... | Geary Richard S | SVP, Development | Buy | J | 35.42 | 177 | 6,269 | 16,857 | 16.7 K to 16.9 K (+1.06 %) |
| Jul 03 2018 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | SVP Finance & CFO | Buy | J | 35.42 | 274 | 9,705 | 14,774 | 14.5 K to 14.8 K (+1.89 %) |
| Jul 03 2018 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | Chief Operating Off ... | Buy | J | 35.42 | 214 | 7,580 | 15,997 | 15.8 K to 16 K (+1.36 %) |
| Jul 03 2018 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP Legal & General ... | Buy | J | 35.42 | 66 | 2,338 | 14,518 | 14.5 K to 14.5 K (+0.46 %) |
| Jul 03 2018 | ISIS | IONIS PHARMACEUTIC ... | LOSCALZO JOSEPH | Director | Option Exercise | A | 42.88 | 16,000 | 686,080 | 16,000 | |
| Jul 03 2018 | ISIS | IONIS PHARMACEUTIC ... | LOSCALZO JOSEPH | Director | Option Exercise | A | 0.00 | 3,555 | 0 | 3,555 | |
| Jul 03 2018 | ISIS | IONIS PHARMACEUTIC ... | LOSCALZO JOSEPH | Director | Option Exercise | M | 0.00 | 667 | 0 | 2,000 | |
| Jul 03 2018 | ISIS | IONIS PHARMACEUTIC ... | LOSCALZO JOSEPH | Director | Option Exercise | M | 0.00 | 2,000 | 0 | 1,999 | |
| Jul 03 2018 | ISIS | IONIS PHARMACEUTIC ... | LOSCALZO JOSEPH | Director | Buy | M | 0.00 | 667 | 0 | 10,419 | 9.8 K to 10.4 K (+6.84 %) |
| Jul 03 2018 | ISIS | IONIS PHARMACEUTIC ... | LOSCALZO JOSEPH | Director | Buy | M | 0.00 | 2,000 | 0 | 9,752 | 7.8 K to 9.8 K (+25.80 %) |
| Jul 03 2018 | ISIS | IONIS PHARMACEUTIC ... | PARSHALL B LYNNE | Director | Option Exercise | A | 42.88 | 16,000 | 686,080 | 16,000 | |
| Jul 03 2018 | ISIS | IONIS PHARMACEUTIC ... | PARSHALL B LYNNE | Director | Option Exercise | A | 0.00 | 3,555 | 0 | 3,555 | |
| Jul 03 2018 | ISIS | IONIS PHARMACEUTIC ... | Castleman Breaux | Director | Option Exercise | A | 42.88 | 16,000 | 686,080 | 16,000 | |
| Jul 03 2018 | ISIS | IONIS PHARMACEUTIC ... | Castleman Breaux | Director | Option Exercise | A | 0.00 | 3,555 | 0 | 3,555 | |
| Jul 03 2018 | ISIS | IONIS PHARMACEUTIC ... | Castleman Breaux | Director | Option Exercise | M | 0.00 | 667 | 0 | 2,000 | |
| Jul 03 2018 | ISIS | IONIS PHARMACEUTIC ... | Castleman Breaux | Director | Option Exercise | M | 0.00 | 2,000 | 0 | 1,999 | |
| Jul 03 2018 | ISIS | IONIS PHARMACEUTIC ... | Castleman Breaux | Director | Buy | M | 0.00 | 667 | 0 | 12,294 | 11.6 K to 12.3 K (+5.74 %) |
| Jul 03 2018 | ISIS | IONIS PHARMACEUTIC ... | Castleman Breaux | Director | Buy | M | 0.00 | 2,000 | 0 | 11,627 | 9.6 K to 11.6 K (+20.77 %) |
| Jul 03 2018 | ISIS | IONIS PHARMACEUTIC ... | WENDER JOSEPH H | Director | Option Exercise | A | 42.88 | 16,000 | 686,080 | 16,000 | |
| Jul 03 2018 | ISIS | IONIS PHARMACEUTIC ... | WENDER JOSEPH H | Director | Option Exercise | A | 0.00 | 3,555 | 0 | 3,555 | |
| Jul 03 2018 | ISIS | IONIS PHARMACEUTIC ... | WENDER JOSEPH H | Director | Option Exercise | M | 0.00 | 667 | 0 | 2,000 | |
| Jul 03 2018 | ISIS | IONIS PHARMACEUTIC ... | WENDER JOSEPH H | Director | Option Exercise | M | 0.00 | 2,000 | 0 | 1,999 | |
| Jul 03 2018 | ISIS | IONIS PHARMACEUTIC ... | WENDER JOSEPH H | Director | Buy | M | 0.00 | 667 | 0 | 38,916 | 38.2 K to 38.9 K (+1.74 %) |
| Jul 03 2018 | ISIS | IONIS PHARMACEUTIC ... | WENDER JOSEPH H | Director | Buy | M | 0.00 | 2,000 | 0 | 38,249 | 36.2 K to 38.2 K (+5.52 %) |
| Jul 03 2018 | ISIS | IONIS PHARMACEUTIC ... | BERTHELSEN SPENCER R | Director | Option Exercise | A | 42.88 | 16,000 | 686,080 | 16,000 | |
| Jul 03 2018 | ISIS | IONIS PHARMACEUTIC ... | BERTHELSEN SPENCER R | Director | Option Exercise | A | 0.00 | 3,555 | 0 | 3,555 | |
| Jul 03 2018 | ISIS | IONIS PHARMACEUTIC ... | BERTHELSEN SPENCER R | Director | Option Exercise | M | 0.00 | 667 | 0 | 2,000 | |
| Jul 03 2018 | ISIS | IONIS PHARMACEUTIC ... | BERTHELSEN SPENCER R | Director | Option Exercise | M | 0.00 | 2,000 | 0 | 1,999 | |
| Jul 03 2018 | ISIS | IONIS PHARMACEUTIC ... | BERTHELSEN SPENCER R | Director | Buy | M | 0.00 | 667 | 0 | 94,094 | 93.4 K to 94.1 K (+0.71 %) |
| Jul 03 2018 | ISIS | IONIS PHARMACEUTIC ... | BERTHELSEN SPENCER R | Director | Buy | M | 0.00 | 2,000 | 0 | 93,427 | 91.4 K to 93.4 K (+2.19 %) |
| Jul 03 2018 | ISIS | IONIS PHARMACEUTIC ... | KLEIN JOSEPH III | Director | Option Exercise | A | 42.88 | 16,000 | 686,080 | 16,000 | |
| Jul 03 2018 | ISIS | IONIS PHARMACEUTIC ... | KLEIN JOSEPH III | Director | Option Exercise | A | 0.00 | 3,555 | 0 | 3,555 | |
| Jul 03 2018 | ISIS | IONIS PHARMACEUTIC ... | KLEIN JOSEPH III | Director | Option Exercise | M | 0.00 | 667 | 0 | 2,000 | |
| Jul 03 2018 | ISIS | IONIS PHARMACEUTIC ... | KLEIN JOSEPH III | Director | Option Exercise | M | 0.00 | 2,000 | 0 | 1,999 | |
| Jul 03 2018 | ISIS | IONIS PHARMACEUTIC ... | KLEIN JOSEPH III | Director | Buy | M | 0.00 | 667 | 0 | 12,606 | 11.9 K to 12.6 K (+5.59 %) |
| Jul 03 2018 | ISIS | IONIS PHARMACEUTIC ... | KLEIN JOSEPH III | Director | Buy | M | 0.00 | 2,000 | 0 | 11,939 | 9.9 K to 11.9 K (+20.12 %) |
| Jun 25 2018 | ISIS | IONIS PHARMACEUTIC ... | BERTHELSEN SPENCER R | Director | Option Exercise | M | 13.88 | 15,000 | 208,200 | 0 | |
| Jun 25 2018 | ISIS | IONIS PHARMACEUTIC ... | BERTHELSEN SPENCER R | Director | Sell | S | 42.47 | 9,300 | 394,971 | 91,427 | 100.7 K to 91.4 K (-9.23 %) |
| Jun 25 2018 | ISIS | IONIS PHARMACEUTIC ... | BERTHELSEN SPENCER R | Director | Buy | M | 13.88 | 9,300 | 129,084 | 100,727 | 91.4 K to 100.7 K (+10.17 %) |
| Jun 25 2018 | ISIS | IONIS PHARMACEUTIC ... | BERTHELSEN SPENCER R | Director | Sell | S | 42.03 | 5,700 | 239,571 | 91,427 | 97.1 K to 91.4 K (-5.87 %) |
| Jun 25 2018 | ISIS | IONIS PHARMACEUTIC ... | BERTHELSEN SPENCER R | Director | Buy | M | 13.88 | 5,700 | 79,116 | 97,127 | 91.4 K to 97.1 K (+6.23 %) |
| Jun 18 2018 | ISIS | IONIS PHARMACEUTIC ... | McDevitt Damien | Chief Business Offi ... | Option Exercise | A | 43.60 | 63,750 | 2,779,500 | 63,750 | |
| May 31 2018 | ISIS | IONIS PHARMACEUTIC ... | MUTO FREDERICK T | Director | Option Exercise | M | 13.88 | 15,000 | 208,200 | 0 | |
| May 31 2018 | ISIS | IONIS PHARMACEUTIC ... | MUTO FREDERICK T | Director | Sell | S | 46.45 | 15,000 | 696,750 | 7,127 | 22.1 K to 7.1 K (-67.79 %) |
| May 31 2018 | ISIS | IONIS PHARMACEUTIC ... | MUTO FREDERICK T | Director | Buy | M | 13.88 | 15,000 | 208,200 | 22,127 | 7.1 K to 22.1 K (+210.47 %) |
| May 11 2018 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | SVP, Antisense Rese ... | Option Exercise | M | 7.25 | 12,500 | 90,625 | 13 | |
| May 11 2018 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | SVP, Antisense Rese ... | Sell | S | 45.00 | 12,500 | 562,500 | 19,114 | 31.6 K to 19.1 K (-39.54 %) |
| May 11 2018 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | SVP, Antisense Rese ... | Buy | M | 7.25 | 12,500 | 90,625 | 31,614 | 19.1 K to 31.6 K (+65.40 %) |
| May 11 2018 | ISIS | IONIS PHARMACEUTIC ... | WENDER JOSEPH H | Director | Option Exercise | M | 13.88 | 15,000 | 208,200 | 0 | |
| May 11 2018 | ISIS | IONIS PHARMACEUTIC ... | WENDER JOSEPH H | Director | Sell | S | 45.03 | 8,590 | 386,808 | 36,249 | 44.8 K to 36.2 K (-19.16 %) |
| May 11 2018 | ISIS | IONIS PHARMACEUTIC ... | WENDER JOSEPH H | Director | Buy | M | 13.88 | 8,590 | 119,229 | 44,839 | 36.2 K to 44.8 K (+23.70 %) |
| May 11 2018 | ISIS | IONIS PHARMACEUTIC ... | WENDER JOSEPH H | Director | Sell | S | 45.79 | 6,010 | 275,198 | 36,249 | 42.3 K to 36.2 K (-14.22 %) |
| May 11 2018 | ISIS | IONIS PHARMACEUTIC ... | WENDER JOSEPH H | Director | Buy | M | 13.88 | 6,010 | 83,419 | 42,259 | 36.2 K to 42.3 K (+16.58 %) |
| May 11 2018 | ISIS | IONIS PHARMACEUTIC ... | WENDER JOSEPH H | Director | Sell | S | 44.02 | 400 | 17,608 | 36,249 | 36.6 K to 36.2 K (-1.09 %) |
| May 11 2018 | ISIS | IONIS PHARMACEUTIC ... | WENDER JOSEPH H | Director | Buy | M | 13.88 | 400 | 5,552 | 36,649 | 36.2 K to 36.6 K (+1.10 %) |
| Apr 19 2018 | ISIS | IONIS PHARMACEUTIC ... | IONIS PHARMACEUTICALS INC | 10% Owner | Buy | P | 18.75 | 10,666,666 | 199,999,988 | 64,114,545 | 53.4 M to 64.1 M (+19.96 %) |
| Apr 19 2018 | ISIS | IONIS PHARMACEUTIC ... | IONIS PHARMACEUTICALS INC | 10% Owner | Buy | J | 0.00 | 8,000,000 | 0 | 53,447,879 | 45.4 M to 53.4 M (+17.60 %) |
| Apr 19 2018 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 10.82 | 4,000 | 43,280 | 2,904 | |
| Apr 19 2018 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 14.69 | 9,962 | 146,342 | 16,680 | |
| Apr 19 2018 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 44.50 | 2,000 | 89,000 | 4,128 | 6.1 K to 4.1 K (-32.64 %) |
| Apr 19 2018 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 10.82 | 2,000 | 21,640 | 6,128 | 4.1 K to 6.1 K (+48.45 %) |
| Apr 19 2018 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 44.30 | 2,000 | 88,600 | 4,128 | 6.1 K to 4.1 K (-32.64 %) |
| Apr 19 2018 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 10.82 | 2,000 | 21,640 | 6,128 | 4.1 K to 6.1 K (+48.45 %) |
| Apr 19 2018 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 44.50 | 4,981 | 221,655 | 51,733 | 56.7 K to 51.7 K (-8.78 %) |
| Apr 19 2018 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 14.69 | 4,981 | 73,171 | 56,714 | 51.7 K to 56.7 K (+9.63 %) |
| Apr 19 2018 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 44.30 | 4,981 | 220,658 | 51,733 | 56.7 K to 51.7 K (-8.78 %) |
| Apr 19 2018 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 14.69 | 4,981 | 73,171 | 56,714 | 51.7 K to 56.7 K (+9.63 %) |
| Mar 30 2018 | ISIS | IONIS PHARMACEUTIC ... | KLEIN JOSEPH III | Director | Option Exercise | M | 24.42 | 2,000 | 48,840 | 0 | |
| Mar 30 2018 | ISIS | IONIS PHARMACEUTIC ... | KLEIN JOSEPH III | Director | Sell | S | 46.15 | 2,000 | 92,300 | 9,939 | 11.9 K to 9.9 K (-16.75 %) |
| Mar 30 2018 | ISIS | IONIS PHARMACEUTIC ... | KLEIN JOSEPH III | Director | Buy | M | 24.42 | 2,000 | 48,840 | 11,939 | 9.9 K to 11.9 K (+20.12 %) |
| Mar 30 2018 | ISIS | IONIS PHARMACEUTIC ... | KLEIN JOSEPH III | Director | Option Exercise | M | 24.42 | 2,000 | 48,840 | 0 | |
| Mar 30 2018 | ISIS | IONIS PHARMACEUTIC ... | KLEIN JOSEPH III | Director | Sell | S | 46.15 | 2,000 | 92,300 | 9,939 | 11.9 K to 9.9 K (-16.75 %) |
| Mar 30 2018 | ISIS | IONIS PHARMACEUTIC ... | KLEIN JOSEPH III | Director | Buy | M | 24.42 | 2,000 | 48,840 | 11,939 | 9.9 K to 11.9 K (+20.12 %) |
| Mar 16 2018 | ISIS | IONIS PHARMACEUTIC ... | KLEIN JOSEPH III | Director | Option Exercise | M | 24.42 | 2,000 | 48,840 | 2,000 | |
| Mar 16 2018 | ISIS | IONIS PHARMACEUTIC ... | KLEIN JOSEPH III | Director | Sell | S | 52.11 | 200 | 10,422 | 9,939 | 10.1 K to 9.9 K (-1.97 %) |
| Mar 16 2018 | ISIS | IONIS PHARMACEUTIC ... | KLEIN JOSEPH III | Director | Buy | M | 24.42 | 200 | 4,884 | 10,139 | 9.9 K to 10.1 K (+2.01 %) |
| Mar 16 2018 | ISIS | IONIS PHARMACEUTIC ... | KLEIN JOSEPH III | Director | Sell | S | 51.59 | 900 | 46,431 | 9,939 | 10.8 K to 9.9 K (-8.30 %) |
| Mar 16 2018 | ISIS | IONIS PHARMACEUTIC ... | KLEIN JOSEPH III | Director | Buy | M | 24.42 | 900 | 21,978 | 10,839 | 9.9 K to 10.8 K (+9.06 %) |
| Mar 16 2018 | ISIS | IONIS PHARMACEUTIC ... | KLEIN JOSEPH III | Director | Sell | S | 50.45 | 900 | 45,405 | 9,939 | 10.8 K to 9.9 K (-8.30 %) |
| Mar 16 2018 | ISIS | IONIS PHARMACEUTIC ... | KLEIN JOSEPH III | Director | Buy | M | 24.42 | 900 | 21,978 | 10,839 | 9.9 K to 10.8 K (+9.06 %) |
| Mar 13 2018 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP Legal & General ... | Option Exercise | M | 10.82 | 1,000 | 10,820 | 400 | |
| Mar 13 2018 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP Legal & General ... | Sell | S | 55.00 | 1,000 | 55,000 | 14,452 | 15.5 K to 14.5 K (-6.47 %) |
| Mar 13 2018 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP Legal & General ... | Buy | M | 10.82 | 1,000 | 10,820 | 15,452 | 14.5 K to 15.5 K (+6.92 %) |
| Mar 01 2018 | ISIS | IONIS PHARMACEUTIC ... | KLEIN JOSEPH III | Director | Option Exercise | M | 35.53 | 3,000 | 106,590 | 0 | |
| Mar 01 2018 | ISIS | IONIS PHARMACEUTIC ... | KLEIN JOSEPH III | Director | Sell | S | 52.29 | 2,100 | 109,809 | 9,939 | 12 K to 9.9 K (-17.44 %) |
| Mar 01 2018 | ISIS | IONIS PHARMACEUTIC ... | KLEIN JOSEPH III | Director | Buy | M | 35.53 | 2,100 | 74,613 | 12,039 | 9.9 K to 12 K (+21.13 %) |
| Mar 01 2018 | ISIS | IONIS PHARMACEUTIC ... | KLEIN JOSEPH III | Director | Sell | S | 51.02 | 900 | 45,918 | 9,939 | 10.8 K to 9.9 K (-8.30 %) |
| Mar 01 2018 | ISIS | IONIS PHARMACEUTIC ... | KLEIN JOSEPH III | Director | Buy | M | 35.53 | 900 | 31,977 | 10,839 | 9.9 K to 10.8 K (+9.06 %) |
| Feb 16 2018 | ISIS | IONIS PHARMACEUTIC ... | KLEIN JOSEPH III | Director | Option Exercise | M | 35.53 | 3,000 | 106,590 | 3,000 | |
| Feb 16 2018 | ISIS | IONIS PHARMACEUTIC ... | KLEIN JOSEPH III | Director | Sell | S | 49.20 | 1,600 | 78,720 | 9,939 | 11.5 K to 9.9 K (-13.87 %) |
| Feb 16 2018 | ISIS | IONIS PHARMACEUTIC ... | KLEIN JOSEPH III | Director | Buy | M | 35.53 | 1,600 | 56,848 | 11,539 | 9.9 K to 11.5 K (+16.10 %) |
| Feb 16 2018 | ISIS | IONIS PHARMACEUTIC ... | KLEIN JOSEPH III | Director | Sell | S | 48.76 | 1,400 | 68,264 | 9,939 | 11.3 K to 9.9 K (-12.35 %) |
| Feb 16 2018 | ISIS | IONIS PHARMACEUTIC ... | KLEIN JOSEPH III | Director | Buy | M | 35.53 | 1,400 | 49,742 | 11,339 | 9.9 K to 11.3 K (+14.09 %) |
| Jan 31 2018 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP Legal & General ... | Option Exercise | M | 10.82 | 300 | 3,246 | 1,400 | |
| Jan 31 2018 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP Legal & General ... | Option Exercise | M | 10.82 | 55 | 595 | 0 | |
| Jan 31 2018 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP Legal & General ... | Sell | S | 55.00 | 300 | 16,500 | 14,452 | 14.8 K to 14.5 K (-2.03 %) |
| Jan 31 2018 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP Legal & General ... | Buy | M | 10.82 | 300 | 3,246 | 14,752 | 14.5 K to 14.8 K (+2.08 %) |
| Jan 31 2018 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP Legal & General ... | Sell | S | 55.00 | 55 | 3,025 | 14,452 | 14.5 K to 14.5 K (-0.38 %) |
| Jan 31 2018 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP Legal & General ... | Buy | M | 10.82 | 55 | 595 | 14,507 | 14.5 K to 14.5 K (+0.38 %) |
| Jan 29 2018 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP Legal & General ... | Option Exercise | M | 10.82 | 645 | 6,979 | 55 | |
| Jan 29 2018 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP Legal & General ... | Sell | S | 55.00 | 645 | 35,475 | 14,452 | 15.1 K to 14.5 K (-4.27 %) |
| Jan 29 2018 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP Legal & General ... | Buy | M | 10.82 | 645 | 6,979 | 15,097 | 14.5 K to 15.1 K (+4.46 %) |
| Jan 17 2018 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | SVP, Finance & CFO | Option Exercise | M | 0.00 | 6,732 | 0 | 10,217 | |
| Jan 17 2018 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | SVP, Finance & CFO | Option Exercise | A | 0.00 | 12,137 | 0 | 12,137 | |
| Jan 17 2018 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | SVP, Finance & CFO | Sell | S | 51.76 | 2,724 | 140,994 | 14,500 | 17.2 K to 14.5 K (-15.82 %) |
| Jan 17 2018 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | SVP, Finance & CFO | Buy | M | 0.00 | 6,732 | 0 | 17,224 | 10.5 K to 17.2 K (+64.16 %) |
| Jan 17 2018 | ISIS | IONIS PHARMACEUTIC ... | KLEIN JOSEPH III | Director | Option Exercise | M | 35.53 | 3,000 | 106,590 | 9,000 | |
| Jan 17 2018 | ISIS | IONIS PHARMACEUTIC ... | KLEIN JOSEPH III | Director | Sell | S | 52.97 | 1,400 | 74,158 | 9,939 | 11.3 K to 9.9 K (-12.35 %) |
| Jan 17 2018 | ISIS | IONIS PHARMACEUTIC ... | KLEIN JOSEPH III | Director | Buy | M | 35.53 | 1,400 | 49,742 | 11,339 | 9.9 K to 11.3 K (+14.09 %) |
| Jan 17 2018 | ISIS | IONIS PHARMACEUTIC ... | KLEIN JOSEPH III | Director | Sell | S | 52.13 | 1,600 | 83,408 | 9,939 | 11.5 K to 9.9 K (-13.87 %) |
| Jan 17 2018 | ISIS | IONIS PHARMACEUTIC ... | KLEIN JOSEPH III | Director | Buy | M | 35.53 | 1,600 | 56,848 | 11,539 | 9.9 K to 11.5 K (+16.10 %) |
| Jan 17 2018 | ISIS | IONIS PHARMACEUTIC ... | Geary Richard S | SVP, Development | Option Exercise | M | 0.00 | 6,732 | 0 | 10,217 | |
| Jan 17 2018 | ISIS | IONIS PHARMACEUTIC ... | Geary Richard S | SVP, Development | Option Exercise | A | 0.00 | 12,916 | 0 | 12,916 | |
| Jan 17 2018 | ISIS | IONIS PHARMACEUTIC ... | Geary Richard S | SVP, Development | Sell | S | 51.76 | 2,723 | 140,942 | 16,680 | 19.4 K to 16.7 K (-14.03 %) |
| Jan 17 2018 | ISIS | IONIS PHARMACEUTIC ... | Geary Richard S | SVP, Development | Buy | M | 0.00 | 6,732 | 0 | 19,403 | 12.7 K to 19.4 K (+53.13 %) |
| Jan 17 2018 | ISIS | IONIS PHARMACEUTIC ... | PARSHALL B LYNNE | Director | Option Exercise | M | 0.00 | 18,339 | 0 | 29,185 | |
| Jan 17 2018 | ISIS | IONIS PHARMACEUTIC ... | PARSHALL B LYNNE | Director | Option Exercise | A | 0.00 | 23,016 | 0 | 23,016 | |
| Jan 17 2018 | ISIS | IONIS PHARMACEUTIC ... | PARSHALL B LYNNE | Director | Sell | S | 51.76 | 5,986 | 309,835 | 38,180 | 44.2 K to 38.2 K (-13.55 %) |
| Jan 17 2018 | ISIS | IONIS PHARMACEUTIC ... | PARSHALL B LYNNE | Director | Buy | M | 0.00 | 18,339 | 0 | 44,166 | 25.8 K to 44.2 K (+71.01 %) |
| Jan 17 2018 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Option Exercise | M | 0.00 | 6,663 | 0 | 10,148 | |
| Jan 17 2018 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Option Exercise | A | 0.00 | 12,141 | 0 | 12,141 | |
| Jan 17 2018 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Sell | S | 51.76 | 2,697 | 139,597 | 14,452 | 17.1 K to 14.5 K (-15.73 %) |
| Jan 17 2018 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Buy | M | 0.00 | 6,663 | 0 | 17,149 | 10.5 K to 17.1 K (+63.54 %) |
| Jan 17 2018 | ISIS | IONIS PHARMACEUTIC ... | Boyce Sarah | Chief Business Offi ... | Option Exercise | M | 0.00 | 5,367 | 0 | 10,427 | |
| Jan 17 2018 | ISIS | IONIS PHARMACEUTIC ... | Boyce Sarah | Chief Business Offi ... | Option Exercise | A | 0.00 | 12,916 | 0 | 12,916 | |
| Jan 17 2018 | ISIS | IONIS PHARMACEUTIC ... | Boyce Sarah | Chief Business Offi ... | Sell | S | 51.76 | 2,196 | 113,665 | 8,931 | 11.1 K to 8.9 K (-19.74 %) |
| Jan 17 2018 | ISIS | IONIS PHARMACEUTIC ... | Boyce Sarah | Chief Business Offi ... | Buy | M | 0.00 | 5,367 | 0 | 11,127 | 5.8 K to 11.1 K (+93.18 %) |
| Jan 17 2018 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | SVP, Antisense Rese ... | Option Exercise | M | 0.00 | 6,663 | 0 | 10,148 | |
| Jan 17 2018 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | SVP, Antisense Rese ... | Option Exercise | A | 0.00 | 12,137 | 0 | 12,137 | |
| Jan 17 2018 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | SVP, Antisense Rese ... | Sell | S | 51.76 | 2,696 | 139,545 | 19,114 | 21.8 K to 19.1 K (-12.36 %) |
| Jan 17 2018 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | SVP, Antisense Rese ... | Buy | M | 0.00 | 6,663 | 0 | 21,810 | 15.1 K to 21.8 K (+43.99 %) |
| Jan 17 2018 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 0.00 | 1,722 | 0 | 3,047 |